Compare Ascendis Pharma A/S (ASND) vs Intel Corp (INTC) Price & Performance

Ascendis Pharma A/STrade

Intel CorpTrade

Price performance (Past 24H)

Key statistics

Ascendis Pharma A/S vs Intel Corp — how do they compare? Ascendis Pharma A/S trades at $255.5 (market cap $16.67B), while Intel Corp trades at $99.64 (market cap $492.85B). The key difference: Intel Corp is far larger — about 29.6× Ascendis Pharma A/S's market cap, and Intel Corp pays a 2.24% dividend while Ascendis Pharma A/S pays none. Which is the better fit depends on your goals.

	ASND	INTC
Market Cap	$16.67B	$492.85B
Sector	Health	Technology
52-Week High	$277.18	$140.94
52-Week Low	$189.74	$21.81
Enterprise Value	$17.04B	$513.66B
Volume	—	43,552,012
Dividend Yield	—	2.24%

View details →View details →

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Ascendis Pharma A/S

No Aura AI signal available yet.

Intel Corp

Intel (INTC) trades at $97.52, down 4.06% today amid a $20 billion stock offering announcement. Despite recent earnings beats, the stock faces pressure from dilution concerns while showing strong revenue growth in data center and AI segments. Technical indicators are bullish on moving averages but neutral on oscillators, with key resistance at $100. Fundamentals reveal a mixed picture with negative net income margins but improving operational cash flow trends.

The outlook remains cautiously optimistic with a $116.67 analyst price target suggesting 20% upside, though execution risks in foundry losses and competitive pressures persist. Investors should weigh the growth potential in AI against near-term dilution and margin challenges.

Aura AI is an analytical signal, not financial advice — do your own research.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

ASND

View details →

INTC

Polen 5Perspectives Large Growth Portfolio outperforms Russell 1000 Growth with 26.63% return in Q2 2026Seeking Alpha · 15 hours agoBullish Intel stock upgraded to Buy as Q2 revenue jumps 25%, margins expand, and outlook beats expectations.Seeking Alpha · 1 day agoBullish Intel stock soars 370% in a year, fueled by Nvidia partnership and AI demand.Finbold · 1 day agoBullish View details →

About Ascendis Pharma A/S

Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.

About Intel Corp

Intel Corporation designs, manufactures, and sells computer components and related products. The Company major products include microprocessors, chipsets, embedded processors and microcontrollers, flash memory, graphic, network and communication, systems management software, conferencing, and digital imaging products.